United States · FDA National Drug Code directory
PREGABALIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72658-0812_4739c18b-9a48-41df-e063-6394a90a3589
- Product NDC
- 72658-0812
- Form
- CAPSULE
- Composition / generic term
- PREGABALIN
- Labeler
- Eskayef Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220404
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (72658-0812-1) · 72658-0812-1
- 90 CAPSULE in 1 BOTTLE (72658-0812-2) · 72658-0812-2
- 6 BLISTER PACK in 1 CARTON (72658-0812-3) / 10 CAPSULE in 1 BLISTER PACK · 72658-0812-3
- 10 BLISTER PACK in 1 CARTON (72658-0812-5) / 10 CAPSULE in 1 BLISTER PACK · 72658-0812-5
- 500 CAPSULE in 1 BOTTLE (72658-0812-6) · 72658-0812-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →